Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
The American Journal of Psychiatry
|
January 1, 1987
Psychotropic drug withdrawal and the dexamethasone suppression test
R P Kraus, M Hux, P Grof
Journal of Psychiatry & Neuroscience : JPN
|
October 24, 1998
The Canadian experience with risperidone for the treatment of schizophrenia: an overview
M Iskedjian, M Hux, G J Remington
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|
January 1, 1982
Kidney function and response to lithium treatment
P Grof, M Hux, B Dressler, et al.
Pharmacopsychiatria
|
November 1, 1983
Prediction of response to stabilizing lithium treatment
P Grof, M Hux, E Grof, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
May 21, 2016
Coverage With Evidence Development Activities Around The World: An Environment Scan
C M Li, N A Risebrough, M Hux
Biological Psychiatry
|
August 1, 1986
Methylene blue validates compliance (ingestion of dexamethasone) on the dexamethasone suppression test
R P Kraus, P Grof, K J Harvey, et al.
Perspectives in Psychiatric Care
|
December 16, 1998
Factors influencing movement of chronic psychiatric patients from the orientation to the working phase of the nurse-client relationship on an inpatient unit
C Forchuk, J Westwell, M L Martin, et al.
Journal of the American Geriatrics Society
|
May 14, 1999
Economic evaluation of donepezil for the treatment of Alzheimer's disease in Canada
B J O'Brien, R Goeree, M Hux, et al.
The Journal of Clinical Psychiatry
|
June 1, 1987
Methylene blue: a reliable and practical marker for validating compliance on the DST
R P Kraus, P Grof, G W Arana, et al.
The British Journal of Psychiatry : the Journal of Mental Science
|
June 1, 1988
A follow-up study on alcoholics with and without co-existing affective disorder
K O'Sullivan, C Rynne, J Miller, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
The American Journal of Psychiatry
|
January 1, 1987
Psychotropic drug withdrawal and the dexamethasone suppression test
R P Kraus, M Hux, P Grof
Journal of Psychiatry & Neuroscience : JPN
|
October 24, 1998
The Canadian experience with risperidone for the treatment of schizophrenia: an overview
M Iskedjian, M Hux, G J Remington
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|
January 1, 1982
Kidney function and response to lithium treatment
P Grof, M Hux, B Dressler, et al.
Pharmacopsychiatria
|
November 1, 1983
Prediction of response to stabilizing lithium treatment
P Grof, M Hux, E Grof, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
May 21, 2016
Coverage With Evidence Development Activities Around The World: An Environment Scan
C M Li, N A Risebrough, M Hux
Biological Psychiatry
|
August 1, 1986
Methylene blue validates compliance (ingestion of dexamethasone) on the dexamethasone suppression test
R P Kraus, P Grof, K J Harvey, et al.
Perspectives in Psychiatric Care
|
December 16, 1998
Factors influencing movement of chronic psychiatric patients from the orientation to the working phase of the nurse-client relationship on an inpatient unit
C Forchuk, J Westwell, M L Martin, et al.
Journal of the American Geriatrics Society
|
May 14, 1999
Economic evaluation of donepezil for the treatment of Alzheimer's disease in Canada
B J O'Brien, R Goeree, M Hux, et al.
The Journal of Clinical Psychiatry
|
June 1, 1987
Methylene blue: a reliable and practical marker for validating compliance on the DST
R P Kraus, P Grof, G W Arana, et al.
The British Journal of Psychiatry : the Journal of Mental Science
|
June 1, 1988
A follow-up study on alcoholics with and without co-existing affective disorder
K O'Sullivan, C Rynne, J Miller, et al.
Page
of 2